Back to top
more

MEDIFAST (MED)

(Real Time Quote from BATS)

$18.20 USD

18.20
100,531

-0.40 (-2.15%)

Updated Aug 30, 2024 01:38 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (93 out of 251)

Industry: Food - Miscellaneous

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Newell to Sell Process Solutions Business for $500 Million

by Zacks Equity Research

Newell (NWL) agrees to sell its Process Solutions business to One Rock Capital Partners, LLC, for $500 million.

Archer Daniels to Expand Citrus Portfolio With Ziegler Buyout

by Zacks Equity Research

Archer Daniels (ADM) to buy Europe-based Ziegler Group to bolster its natural citrus flavor portfolio. This follows the recent buyout of Florida Chemical based in the United States.

Newell's Contigo Launches LUXE, a Spill-Proof Collection

by Zacks Equity Research

Newell's (NWL) Contigo brand launches the LUXE Collection, extending its stainless steel thermal and hydration lines.

Can Kraft Heinz's Potential Sale of Breakstone's Aid Growth?

by Zacks Equity Research

Kraft Heinz (KHC) has appointed Royal Bank of Canada to assess alternatives for its Breakstone's sour cream and cottage cheese business, per sources. This could also involve a potential sale.

Can Newell's (NWL) Transformation Plan Offset Sales Woes?

by Zacks Equity Research

Newell's (NWL) dismal sales surprise trend can be attributed to lower core sales and adverse foreign currency. Nevertheless, its Transformation Plan appear encouraging.

Procter & Gamble Hits 52-Week High: What's Behind the Rally?

by Zacks Equity Research

Procter & Gamble (PG) gains from its solid focus on product improvement, packaging and marketing initiatives, and productivity and cost-savings plan.

Here's Why Investors Should Buy Clorox (CLX) Stock Right Now

by Zacks Equity Research

Clorox (CLX) gains from strategic initiatives including smooth execution of the 2020 Strategy, focus on e-commerce business and brand management efforts.

David Borun headshot

Friday Rebound Takes the Sting out of a Tough Week

by David Borun

US equity markets recover from a Friday slide but still post their worst week of 2019

Kellogg Down on Soft U.S. Snacks & Morning Foods Businesses

by Zacks Equity Research

Kellogg (K) grapples with high costs related to brand enhancement, stiff competition, adverse currency effects, and weak U.S. snacks and Morning Foods businesses.

Medifast, Eldorado Resorts, Salesforce, Boeing, Starbucks and WPP highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Medifast, Eldorado Resorts, Salesforce, Boeing, Starbucks and WPP highlighted as Zacks Bull and Bear of the Day

Kraft Heinz (KHC) to Expand Customer Base With Farmstead Deal

by Zacks Equity Research

Kraft Heinz (KHC) ties up with online grocer, Farmstead. This is likely to help Kraft Heinz reach more consumers through online orders and deliveries.

David Borun headshot

Bull of the Day: Medifast (MED)

by David Borun

This innovative weight-loss company is producing better results than household name competitors with its innovative strategy

Archer Daniels Acquires FCC, Boosts Citrus Flavors Portfolio

by Zacks Equity Research

Archer Daniels (ADM) has acquired Florida Chemical's Consumer and Industrial Chemistry Technologies segment for $175 million in cash.

Sheraz Mian headshot

Q4 Earnings Top Estimates, Revenues Miss

by Sheraz Mian

3D Systems Corporation delivered non-GAAP earnings of 10 cents per share for fourth-quarter 2018

David Borun headshot

Friday Rally Helps the Markets Recover Earlier Weekly Losses

by David Borun

Positive earnings data and an end to the government shutdown help keep the 2019 rally gooing

Sreyoshi Mukherjee headshot

3 Weight-Loss Stocks in Focus on Rising Obesity Fears

by Sreyoshi Mukherjee

Three companies with bright prospects as the U.S. weight-loss industry keeps up its battle against obesity.

Medifast (MED) Misses Q3 Earnings Estimates

by Zacks Equity Research

Medifast (MED) delivered earnings and revenue surprises of -0.87% and 11.04%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

Medifast (MED) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Medifast (MED) closed the most recent trading day at $214.20, moving +1.19% from the previous trading session.

Medifast (MED) Q3 Earnings: Coaches & OPTAVIA are Key Drivers

by Zacks Equity Research

Medifast's (MED) Q3 performance to gain from a sturdy coach base and advancement in the OPTAVIA brand.

Medifast (MED) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Medifast (MED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Medifast (MED) Stock Moves -0.77%: What You Should Know

by Zacks Equity Research

Medifast (MED) closed the most recent trading day at $204.93, moving -0.77% from the previous trading session.

SYY or MED: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

SYY vs. MED: Which Stock Is the Better Value Option?

The Zacks Analyst Blog Highlights: Champions Oncology, General Finance, Tilly's, Armstrong Flooring and Medifast

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Champions Oncology, General Finance, Tilly's, Armstrong Flooring and Medifast

    Nalak Das headshot

    Wall Street Bulls to Flourish in Q4: 5 Solid Growth Picks

    by Nalak Das

    Despite trade war concerns, a robust U.S. economy and strong earnings results boosted investors' confidence in the stock markets.

      Here's Why McCormick (MKC) is Sizzling in the Culinary Space

      by Zacks Equity Research

      McCormick's (MKC) top line gains from impressive brands performance. Yielding buyouts strengthens portfolio further.